Teladoc Health Inc.(TDOC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TDOC Teladoc Health Inc.

Closed Good Friday 04-17 16:00:00 EDT

6.83

-0.07

-1.01%

盘后6.83

+0.000.00%

19:57 EDT

High6.96	Low6.76	Vol3.84M
Open6.85	D1 Closing6.90	Amplitude2.86%
Mkt Cap1.20B	Tradable Cap1.10B	Total Shares175.28M
T/O26.22M	T/O Rate2.38%	Tradable Shares161.19M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"TDOC","market":"US","secType":"STK","nameCN":"Teladoc Health Inc.","latestPrice":6.83,"timestamp":1744920000000,"preClose":6.9,"halted":0,"volume":3835687,"hourTrading":{"tag":"盘后","latestPrice":6.83,"preClose":6.83,"latestTime":"19:57 EDT","volume":86683,"amount":592195.4018,"timestamp":1744934275653},"delay":0,"floatShares":161194181,"shares":175277825,"eps":-5.870198,"marketStatus":"Closed Good Friday","change":-0.07,"latestTime":"04-17 16:00:00 EDT","open":6.85,"high":6.96,"low":6.7625,"amount":26218619.854341,"amplitude":0.028623,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.870198,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1435723200000,"exchange":"NYSE","adjPreClose":6.9,"preHourTrading":{"tag":"盘前","latestPrice":6.91,"preClose":6.9,"latestTime":"09:27 EDT","volume":9105,"amount":63327.787979999994,"timestamp":1744896431599},"postHourTrading":{"tag":"盘后","latestPrice":6.83,"preClose":6.83,"latestTime":"19:57 EDT","volume":86683,"amount":592195.4018,"timestamp":1744934275653},"volumeRatio":0.7915098924977249,"impliedVol":1.1395,"impliedVolPercentile":0.9442},"requestUrl":"/m/hq/s/TDOC","defaultTab":"news","newsList":[{"id":"2528012902","title":"Teladoc Health to Announce First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2528012902","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528012902?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 06:00","pubTimestamp":1744840800,"startTime":"0","endTime":"0","summary":"PURCHASE, NY, April 16, 2025  -- Teladoc Health Inc. , the global leader in virtual care, announced that it will release first quarter 2025 results on Wednesday, April 30, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day.A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teladoc-health-announce-first-quarter-220000588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861559042.SGD","BK4167","BK4567","BK4534","LU1861558580.USD","BK4588","BK4548","TDOC","BK4504","BK4585"],"gpt_icon":0},{"id":"2527034247","title":"Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it","url":"https://stock-news.laohu8.com/highlight/detail?id=2527034247","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527034247?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 20:43","pubTimestamp":1744807380,"startTime":"0","endTime":"0","summary":"Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late, which are much lower than the gains experienced till mid-February. The San Francisco, CA-based health and wellness platform’s stock has had a bumpy ride since then. It has gained 5.8% against the industry’s 2.1% decline in the same time frame, outperforming the sector and S&P 500’s 5.2% and 10.4% declines, respectively.Two major developments of HIMS in recent months are the announcement of its promising fourth-quarter 2024 results and the acquisition of a U.S.-based peptide facility based in California . The buyout will likely enable it to strengthen the long-term durability of its domestic supply chain to meet the growing demand from Americans for personalized healthcare and treatment options.However, HIMS’ earnings per share missed the Zacks Consensus Estimate by a penny in the last reported quarter. The gross margin also contracted due to rising product costs, which did not","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hims-hers-stock-gains-5-124300726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999002232.USD","LU1061106388.HKD","SGXZ23171101.USD","BK4196","LU0868494617.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","LU1721429741.USD","LU2237957811.SGD","LU0266013472.USD","BK4568","LU0234572021.USD","LU1057294990.SGD","LU2237957902.USD","TDOC","BK4534","LU2468319806.SGD","BK4167","IE00BJT1NW94.SGD","LU1861558580.USD","LU1861559042.SGD","LU2112291526.USD","LU1721429402.USD","ABT","IE0009355771.USD","SG9999002224.SGD","SG9999004303.SGD","BK4082","BK4504","HIMS","LU0170899867.USD","LU1989763427.SGD","BK4566","BK4567","BK4588","BK4585","LU0122379950.USD","BK4548","IE0002141913.USD","BK4581","BK4533","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1914381329.SGD","BK4592","LU1989763690.USD","LU2133065610.SGD","LU1691799644.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD"],"gpt_icon":1},{"id":"2526663385","title":"Teladoc Health Is Maintained at Neutral by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2526663385","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526663385?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 19:56","pubTimestamp":1744372560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TDOC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 11, 2025 07:56 ET (11:56 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TDOC"],"gpt_icon":0},{"id":"2526906659","title":"Teladoc’s Uncertain Growth Amid Declining User Base and Strategic Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2526906659","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526906659?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 18:16","pubTimestamp":1744366615,"startTime":"0","endTime":"0","summary":"Analyst Allen Lutz from Bank of America Securities reiterated a Hold rating on Teladoc (TDOC – Research Report) and decreased the price target to $...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/teladocs-uncertain-growth-amid-declining-user-base-and-strategic-initiatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/teladocs-uncertain-growth-amid-declining-user-base-and-strategic-initiatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765489.SGD","LU0320765646.SGD","LU0321505439.SGD","LU2129689514.USD","BK4167","LU0256863902.USD","BK4567","TDOC","LU1718418525.SGD","LU1496350502.SGD","LU0053666078.USD","LU0683600562.USD","LU0130102774.USD","LU0070302665.USD","LU0980610538.SGD","LU0310800965.SGD","LU0208291251.USD","LU0868494617.USD","LU1496350171.SGD","BK4207","LU0477156797.USD","IE00BFXG1179.USD","BK4588","LU0321505868.SGD","LU0417517546.SGD","LU0130518102.USD","BK4553","LU0234572021.USD","LU0130103400.USD","IE00BBT3K403.USD","LU1894683348.USD","LU0170899867.USD","LU2133065610.SGD","BK4581","BK4585","IE00BLSP4452.SGD","LU0256863811.USD","LU0306807586.USD","LU1506573853.SGD","IE00B19Z3B42.SGD","LU0106831901.USD","IE00B7SZLL34.SGD","LU2129689605.HKD","IE00BLSP4239.USD","LU1861559042.SGD","LU1791807156.HKD","BK4548","LU1074936037.SGD","LU1280957306.USD"],"gpt_icon":0},{"id":"2526827886","title":"Teladoc (TDOC) Stock Moves -0.97%: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2526827886","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526827886?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 06:15","pubTimestamp":1744150516,"startTime":"0","endTime":"0","summary":"Teladoc  ended the recent trading session at $7.16, demonstrating a -0.97% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily loss of 1.57%. At the same time, the Dow lost 0.84%, and the tech-heavy Nasdaq lost 2.15%.The telehealth services provider's shares have seen a decrease of 19.04% over the last month, not keeping up with the Medical sector's loss of 12.86% and the S&P 500's loss of 12.16%.The investment community will be closely monitoring the performance of Teladoc in its forthcoming earnings report. The company is predicted to post an EPS of -$0.32, indicating a 34.69% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $617.67 million, down 4.4% from the year-ago period.Any recent changes to analyst estimates for Teladoc should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. Hence, positive a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teladoc-tdoc-stock-moves-0-221516160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","TDOC","LU1861558580.USD","BK4567","BK4167","BK4585","BK4504","BK4534","LU1861559042.SGD","BK4548"],"gpt_icon":0},{"id":"2525861432","title":"Teladoc Health Introduces Next Generation Cardiometabolic Health Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2525861432","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525861432?lang=en_us&edition=full_marsco","pubTime":"2025-04-08 18:00","pubTimestamp":1744106400,"startTime":"0","endTime":"0","summary":"New resources aim to improve population health and prevent the progression of diabetes, hypertension and obesityPURCHASE, NY, April  08, 2025  (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the glob","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/08/3057421/0/en/Teladoc-Health-Introduces-Next-Generation-Cardiometabolic-Health-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4504","BK4167","LU1861558580.USD","LU1861559042.SGD","BK4567","BK4588","BK4585","TDOC","BK4548"],"gpt_icon":0},{"id":"2524458354","title":"Teladoc Health (NYSE:TDOC) Expands Connected Care Partnerships Amid US Tariff Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2524458354","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524458354?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 01:47","pubTimestamp":1743616073,"startTime":"0","endTime":"0","summary":"Teladoc Health experienced a 10% decline in share price over the past week, despite announcing significant expansions in its connected care partnerships and pharmacy integration agreements. These developments, including partnerships with Carrot Fertility and Eli Lilly, reflect the company's efforts to enhance its healthcare offerings. However, these announcements occurred amid a volatile market backdrop, with investors bracing for potential U.S. tariff announcements impacting broader market sentiment. Despite these industry advances from Teladoc, market conditions and uncertainties contributed to its overall price movement, as major stock indexes showed gains of about 0.4% to 0.9%, contrasting the broader market's 3% drop.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teladoc-health-nyse-tdoc-expands-174753108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4504","BK4534","TDOC","BK4548","BK4567","LU1861558580.USD","LU1861559042.SGD","BK4585","BK4167","BK4588","NYSE"],"gpt_icon":0},{"id":"2524119914","title":"Teladoc call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2524119914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524119914?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 00:45","pubTimestamp":1743612311,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Teladoc (TDOC) with 7,109 calls trading, 1.3x expected, and implied vol increasing almost 2 points to 78.51%. Apr-2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teladoc-call-volume-above-normal-and-directionally-bullish-39?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teladoc-call-volume-above-normal-and-directionally-bullish-39?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4588","BK4548","TDOC","BK4567","LU1861559042.SGD","BK4585","BK4504","BK4167","LU1861558580.USD"],"gpt_icon":0},{"id":"2524140689","title":"Hims & Hers to Sell Lilly's Weight-Loss Drug on Its Telehealth Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2524140689","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524140689?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 10:04","pubTimestamp":1743559469,"startTime":"0","endTime":"0","summary":"(Reuters) - Telehealth firm $Hims & Hers Health(HIMS)$ said on Tuesday it plans to sell Eli Lilly's LLY.N weight-loss drug, as it widens its offerings to offset any impact from impending restrictions ","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3N3QF1E5:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hims & Hers to Sell Lilly's Weight-Loss Drug on Its Telehealth Platform","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689472784.USD","LU1291159041.SGD","LU2361044865.SGD","LU2361044949.HKD","LU0114720955.EUR","LLY","LU0203202063.USD","LU0471298777.SGD","LU1989771016.USD","BK4196","IE00BK4W5M84.HKD","IE00BJT1NW94.SGD","LU0096364046.USD","LU0823416689.USD","LU1093756325.SGD","SG9999013999.USD","IE00BK4W5L77.USD","LU1061106388.HKD","LU0289739699.SGD","LU2491050071.SGD","BK4581","BK4007","LU1868836757.USD","HIMS","SGXZ31699556.SGD","LU1868837300.USD","BK4534","LU1720051017.SGD","BK4585","TDOC","LU1720051108.HKD","LU2237438978.USD","SGXZ57979304.SGD","IE00BJLML261.HKD","LU2265009873.SGD","SG9999001176.USD","LU2552382132.HKD","LU0820561818.USD","LU2552382215.SGD","SG9999001176.SGD","LU0256863902.USD","LU0882574139.USD","LU1983299246.USD","LU2357305700.SGD","LU2112291526.USD","LU1127390331.HKD","SGXZ99366536.SGD","LU1861559042.SGD","IE00B2B36J28.USD"],"gpt_icon":1},{"id":"2524285911","title":"BUZZ-Hims & Hers rises after plan to sell Eli Lilly's weight loss drug on its platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2524285911","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524285911?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 02:23","pubTimestamp":1743531787,"startTime":"0","endTime":"0","summary":"BUZZ-Hims & Hers rises after plan to sell Eli Lilly's weight loss drug on its platform** Shares of telehealth firm Hims & Hers HIMS.N rise 11.2% to $32.88 ** HIMS says it plans  to sell Eli Lilly's LL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3N3QF1EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0471298694.HKD","LU2361044949.HKD","LU1093756168.USD","BK4167","LU1280957306.USD","LU1861558580.USD","LU1720051017.SGD","IE0004445239.USD","LU0058720904.USD","LU2211815571.USD","LU0079474960.USD","LU1974910355.USD","IE00B4R5TH58.HKD","LU0096364046.USD","LU2237443465.HKD","SG9999001176.USD","LU0820561909.HKD","LU1983299246.USD","BK4007","TDOC","LU0256863902.USD","IE00B2B36J28.USD","BK4585","LU1267930730.SGD","LU1868837300.USD","LU0708995401.HKD","LU0820561818.USD","LU1861559042.SGD","LU1804176565.USD","LU2360106947.USD","SG9999015952.SGD","LU0456855351.SGD","LU2324357040.USD","LLY","HIMS","SG9999015945.SGD","LFMD","LU0689472784.USD","LU1291159041.SGD","SG9999018865.SGD","LU0097036916.USD","BK4516","LU0238689110.USD","LU2237443895.HKD","LU2023250504.SGD","LU1868837136.USD","LU2089984988.USD","SG9999017495.SGD","SGXZ57979304.SGD","LU0882574055.USD"],"gpt_icon":1},{"id":"1198149062","title":"Stock Track | Teladoc Health Plummets 5.71% as Negative Trend Persists Following Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1198149062","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198149062?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 01:44","pubTimestamp":1743183868,"startTime":"0","endTime":"0","summary":"Teladoc Health Inc.  saw its stock plummet 5.71% during Friday's intraday trading, continuing a downward trend that has plagued the company since its last earnings report. This sharp decline adds to the approximately 9.9% loss the stock has experienced over the past month, significantly underperforming the S&P 500 index.The telehealth giant's recent struggles come despite some positive signals from analysts. Fresh estimates for Teladoc have trended upward during the past month, with the consensu","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Teladoc Health Plummets 5.71% as Negative Trend Persists Following Earnings Report","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TDOC"],"gpt_icon":0},{"id":"2523686680","title":"Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523686680","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523686680?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 23:30","pubTimestamp":1743175849,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Teladoc . Shares have lost about 9.9% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Teladoc due for a breakout?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.It turns out, fresh estimates have trended upward during the past month.The consensus estimate has shifted 6.15% due to these changes.Teladoc belongs to the Zacks Medical Services industry. Another stock from the same industry, CVS Health , has gained 4.8% over the past month. More than a month has passed since the company reported results for the quarter ended December 2024.Teladoc Health, Inc.  : Free Stock Analysis Report. CVS Health Corporation  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-teladoc-tdoc-down-9-153049272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CVS","TDOC"],"gpt_icon":0},{"id":"2522363626","title":"Teladoc (TDOC) Flat As Market Sinks: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2522363626","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522363626?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 06:15","pubTimestamp":1743027317,"startTime":"0","endTime":"0","summary":"The most recent trading session ended with Teladoc  standing at $8.64, reflecting no shift from the previouse trading day's closing. The stock's change was more than the S&P 500's daily loss of 1.12%. Elsewhere, the Dow saw a downswing of 0.31%, while the tech-heavy Nasdaq depreciated by 2.04%.Shares of the telehealth services provider have depreciated by 22.72% over the course of the past month, underperforming the Medical sector's loss of 2.99% and the S&P 500's loss of 2.91%.The upcoming earnings release of Teladoc will be of great interest to investors. The company is predicted to post an EPS of -$0.32, indicating a 34.69% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $617.67 million, down 4.4% from the year-ago period.Investors should also note any recent changes to analyst estimates for Teladoc. These revisions help to show the ever-changing nature of near-term business trends. As a result, we c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teladoc-tdoc-flat-market-sinks-221517265.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861559042.SGD","BK4167","BK4504","BK4548","BK4567","TDOC","BK4534","LU1861558580.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2520246111","title":"Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2520246111","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520246111?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 06:15","pubTimestamp":1742422515,"startTime":"0","endTime":"0","summary":"Teladoc  closed at $8.49 in the latest trading session, marking a +1.19% move from the prior day. The stock outpaced the S&P 500's daily gain of 1.08%. At the same time, the Dow added 0.92%, and the tech-heavy Nasdaq gained 1.41%.Coming into today, shares of the telehealth services provider had lost 36% in the past month. In that same time, the Medical sector gained 0.21%, while the S&P 500 lost 8.26%.Market participants will be closely following the financial results of Teladoc in its upcoming release. On that day, Teladoc is projected to report earnings of -$0.33 per share, which would represent year-over-year growth of 32.65%. Meanwhile, the latest consensus estimate predicts the revenue to be $618.17 million, indicating a 4.33% decrease compared to the same quarter of the previous year.Investors should also take note of any recent adjustments to analyst estimates for Teladoc. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estim","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teladoc-tdoc-exceeds-market-returns-221515468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4567","LU1861559042.SGD","BK4534","BK4588","BK4167","TDOC","BK4548","BK4504","BK4585","LU1861558580.USD"],"gpt_icon":0},{"id":"2520939931","title":"Teladoc Health (TDOC): Among the Best Diabetes Stocks to Buy According to Billionaires","url":"https://stock-news.laohu8.com/highlight/detail?id=2520939931","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520939931?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 01:49","pubTimestamp":1742320164,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Teladoc Health, Inc.  stands against other best diabetes stocks to buy according to billionaires.The Growing Market and Innovation in Continuous Glucose Monitoring  Technology. The GlobalData marketed products database shows that there are currently 97 products in the CGM category. Most of these devices are standard CGMs, with only a few being implanted sensors. 133 products are either approved or in the development stage, according to the GlobalData pipeline products database. The research indicates that this market niche is expanding quickly and is a hub for innovative new technologies like implantable CGMs.Twelve percent of adult Americans report having taken a GLP-1 drug at some point, according to the most recent KFF Health Tracking poll. In the previous five years,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teladoc-health-tdoc-among-best-174924642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","BK4585","BK4504","LU1861559042.SGD","BK4159","CAGR","BK4167","BK4588","BK4567","BK4534","TDOC","LU1861558580.USD"],"gpt_icon":0},{"id":"1172824302","title":"Stock Track | Teladoc Health Plummets 5% as Q4 Earnings and Challenges Continue to Weigh on Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1172824302","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172824302?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 23:08","pubTimestamp":1742310509,"startTime":"0","endTime":"0","summary":"Teladoc Health Inc.  saw its stock plummet by 5.02% in Tuesday's trading session, continuing a downward trend following the company's disappointing fourth-quarter earnings report. The telehealth provider has been grappling with ongoing challenges in its business, particularly in its mental health segment, BetterHelp.In its recent earnings release, Teladoc reported revenues of $640.5 million, which was in line with analysts' expectations but represented a 3% year-over-year decline. More concernin","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TDOC"],"gpt_icon":0},{"id":"1179861070","title":"Stock Track | Teladoc Health Plummets 5.02% as Q4 Results and Guidance Disappoint Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=1179861070","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179861070?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 23:08","pubTimestamp":1742310508,"startTime":"0","endTime":"0","summary":"Shares of Teladoc Health Inc.  plummeted 5.02% in Tuesday's trading session, as investors continued to react negatively to the company's recent fourth-quarter earnings report and disappointing guidance. The telehealth provider has been facing challenges in its business environment, particularly in its mental health segment.Teladoc reported Q4 revenues of $640.5 million, representing a 3% year-over-year decline. While this figure was in line with analysts' expectations, the company's full-year EB","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Teladoc Health Plummets 5.02% as Q4 Results and Guidance Disappoint Investors","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TDOC"],"gpt_icon":0},{"id":"2520649549","title":"Teladoc price target lowered to $9.50 from $11 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2520649549","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520649549?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 18:45","pubTimestamp":1742208331,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on Teladoc (TDOC) to $9.50 from $11 and keeps a Neutral rating on the shares. Sensor Tower trends suggest Q1 t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teladoc-price-target-lowered-to-9-50-from-11-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teladoc-price-target-lowered-to-9-50-from-11-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TDOC"],"gpt_icon":0},{"id":"2520563961","title":"Teladoc Health Inc : JP Morgan Cuts Target Price to $11 From $13","url":"https://stock-news.laohu8.com/highlight/detail?id=2520563961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520563961?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 12:15","pubTimestamp":1742184950,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nFWN3Q0002:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861559042.SGD","BK4167","BK4504","BK4548","BK4567","TDOC","BK4534","LU1861558580.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2519866774","title":"Teladoc Expands Specialty Care Access With Carrum Health Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2519866774","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519866774?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 02:35","pubTimestamp":1741890900,"startTime":"0","endTime":"0","summary":"Teladoc HealthTDOC recently announced its partnership with Carrum Health in a bid to streamline specialty care access. This collaboration aims to provide Teladoc’s extensive employer client base and 93 million members with seamless access to Carrum’s high-quality provider network.With healthcare costs rising at an estimated 8% in 2025, employers are seeking cost-effective and well-integrated healthcare solutions. The partnership with Carrum Health allows Teladoc to enhance its Connected Care program, ensuring that employer clients can adopt Carrum’s COE network without additional procurement burdens. Through prebuilt clinical, digital, and data integrations, Teladoc will improve care coordination, increase engagement, and ultimately drive down healthcare expenses.The Zacks Consensus Estimate for Addus HomeCare’s current-year earnings indicates a 13.5% increase from the year-ago reported figure. ADUS beat earnings estimates in three of the trailing four quarters and met once, with an av","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teladoc-expands-specialty-care-access-183500050.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","IE00BN0W2T93.GBP","MD","IE00BN0W2V16.EUR","BK4185","BK4504","TDOC","LU1861558580.USD","LU1861559042.SGD","BK4534","BK4588","BK4567","BK4196","IE00BN0W2W23.USD","BK4167","BK4585","ENSG","ADUS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.teladochealth.com","stockEarnings":[{"period":"1week","weight":-0.0566},{"period":"1month","weight":-0.1859},{"period":"3month","weight":-0.2486},{"period":"6month","weight":-0.3059},{"period":"1year","weight":-0.4802},{"period":"ytd","weight":-0.2486}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.111686},{"month":2,"riseRate":0.4,"avgChangeRate":-0.029697},{"month":3,"riseRate":0.4,"avgChangeRate":-0.047876},{"month":4,"riseRate":0.5,"avgChangeRate":-0.044749},{"month":5,"riseRate":0.555556,"avgChangeRate":0.008366},{"month":6,"riseRate":0.777778,"avgChangeRate":0.106381},{"month":7,"riseRate":0.666667,"avgChangeRate":0.053324},{"month":8,"riseRate":0.3,"avgChangeRate":-0.075128},{"month":9,"riseRate":0.5,"avgChangeRate":-0.002342},{"month":10,"riseRate":0.3,"avgChangeRate":-0.018384},{"month":11,"riseRate":0.7,"avgChangeRate":0.040427},{"month":12,"riseRate":0.2,"avgChangeRate":-0.083364}],"exchange":"NYSE","name":"Teladoc Health Inc.","nameEN":"Teladoc Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Teladoc Health Inc.(TDOC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Teladoc Health Inc.(TDOC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Teladoc Health Inc.,TDOC,Teladoc Health Inc.股票,Teladoc Health Inc.股票老虎,Teladoc Health Inc.股票老虎国际,Teladoc Health Inc.行情,Teladoc Health Inc.股票行情,Teladoc Health Inc.股价,Teladoc Health Inc.股市,Teladoc Health Inc.股票价格,Teladoc Health Inc.股票交易,Teladoc Health Inc.股票购买,Teladoc Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Teladoc Health Inc.(TDOC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Teladoc Health Inc.(TDOC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction